SREBP2, encoded by the SREBF2 gene, has been demonstrated to support cell survival in prostate cancer through accumulation of cholesterol, and its inhibition is suggested as a potential cancer therapy [23]. The gene discussed is SREBF2; the disease is prostate carcinoma.